Wells Fargo’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.2M | Sell |
179,488
-44,601
| -20% | -$4.09M | ﹤0.01% | 1665 |
|
|
2025
Q4 | $20.2M | Buy |
224,089
+2,219
| +1% | +$210K | ﹤0.01% | 1491 |
|
|
2025
Q3 | $21.9M | Buy |
221,870
+34,945
| +19% | +$3.46M | ﹤0.01% | 1414 |
|
|
2025
Q2 | $17M | Sell |
186,925
-5,575
| -3% | -$539K | ﹤0.01% | 1519 |
|
|
2025
Q1 | $21.8M | Sell |
192,500
-3,689
| -2% | -$395K | ﹤0.01% | 1277 |
|
|
2024
Q4 | $20.7M | Sell |
196,189
-69,361
| -26% | -$7.44M | ﹤0.01% | 1330 |
|
|
2024
Q3 | $28.7M | Buy |
265,550
+832
| +0.3% | +$90.8K | 0.01% | 1081 |
|
|
2024
Q2 | $28.7M | Buy |
264,718
+69,354
| +35% | +$8.18M | 0.01% | 1020 |
|
|
2024
Q1 | $25.8M | Sell |
195,364
-22,520
| -10% | -$2.81M | 0.01% | 1076 |
|
|
2023
Q4 | $26.5M | Sell |
217,884
-20,312
| -9% | -$2.27M | 0.01% | 1010 |
|
|
2023
Q3 | $26.7M | Sell |
238,196
-86,303
| -27% | -$11M | 0.01% | 940 |
|
|
2023
Q2 | $47.2M | Buy |
324,499
+21,646
| +7% | +$2.94M | 0.01% | 726 |
|
|
2023
Q1 | $39.1M | Sell |
302,853
-1,673
| -0.5% | -$210K | 0.01% | 785 |
|
|
2022
Q4 | $38.8M | Buy |
304,526
+5,075
| +2% | +$589K | 0.01% | 777 |
|
|
2022
Q3 | $31.3M | Sell |
299,451
-63,066
| -17% | -$6.92M | 0.01% | 848 |
|
|
2022
Q2 | $38.1M | Sell |
362,517
-185,141
| -34% | -$22M | 0.01% | 791 |
|
|
2022
Q1 | $70M | Sell |
547,658
-2,740
| -0.5% | -$330K | 0.02% | 629 |
|
|
2021
Q4 | $67.9M | Sell |
550,398
-1,830,372
| -77% | -$240M | 0.02% | 653 |
|
|
2021
Q3 | $338M | Sell |
2,380,770
-600
| -0% | -$88.3K | 0.07% | 253 |
|
|
2021
Q2 | $372M | Buy |
2,381,370
+7,045
| +0.3% | +$1.14M | 0.08% | 234 |
|
|
2021
Q1 | $369M | Sell |
2,374,325
-91,983
| -4% | -$14.2M | 0.08% | 227 |
|
|
2020
Q4 | $369M | Buy |
2,466,308
+172,084
| +8% | +$24.3M | 0.09% | 220 |
|
|
2020
Q3 | $303M | Sell |
2,294,224
-207,141
| -8% | -$27.1M | 0.08% | 226 |
|
|
2020
Q2 | $290M | Buy |
2,501,365
+90,426
| +4% | +$10.4M | 0.08% | 232 |
|
|
2020
Q1 | $237M | Buy |
2,410,939
+19,318
| +0.8% | +$2.53M | 0.08% | 234 |
|
|
2019
Q4 | $348M | Buy |
2,391,621
+53,373
| +2% | +$7.37M | 0.09% | 203 |
|
|
2019
Q3 | $312M | Buy |
2,338,248
+231,707
| +11% | +$29.9M | 0.09% | 213 |
|
|
2019
Q2 | $241M | Sell |
2,106,541
-8,263
| -0.4% | -$968K | 0.07% | 280 |
|
|
2019
Q1 | $262M | Sell |
2,114,804
-134,982
| -6% | -$15.3M | 0.08% | 244 |
|
|
2018
Q4 | $227M | Buy |
2,249,786
+105,027
| +5% | +$11.8M | 0.08% | 260 |
|
|
2018
Q3 | $274M | Sell |
2,144,759
-97,144
| -4% | -$11.6M | 0.08% | 258 |
|
|
2018
Q2 | $243M | Sell |
2,241,903
-139,913
| -6% | -$15.2M | 0.07% | 278 |
|
|
2018
Q1 | $252M | Buy |
2,381,816
+276,110
| +13% | +$32.1M | 0.07% | 280 |
|
|
2017
Q4 | $247M | Buy |
2,105,706
+1,046,567
| +99% | +$118M | 0.07% | 291 |
|
|
2017
Q3 | $120M | Buy |
1,059,139
+388,919
| +58% | +$44.9M | 0.04% | 481 |
|
|
2017
Q2 | $83.5M | Sell |
670,220
-174,318
| -21% | -$20.7M | 0.03% | 618 |
|
|
2017
Q1 | $100M | Buy |
844,538
+6,361
| +0.8% | +$721K | 0.03% | 531 |
|
|
2016
Q4 | $84M | Buy |
838,177
+45,463
| +6% | +$4.87M | 0.03% | 578 |
|
|
2016
Q3 | $100M | Sell |
792,714
-136,383
| -15% | -$16.9M | 0.04% | 505 |
|
|
2016
Q2 | $109M | Buy |
929,097
+273,144
| +42% | +$30.9M | 0.04% | 449 |
|
|
2016
Q1 | $67.9M | Sell |
655,953
-10,175
| -2% | -$984K | 0.03% | 616 |
|
|
2015
Q4 | $66.3M | Sell |
666,128
-11,906
| -2% | -$1.16M | 0.03% | 631 |
|
|
2015
Q3 | $61.8M | Sell |
678,034
-114,444
| -14% | -$11.5M | 0.03% | 652 |
|
|
2015
Q2 | $84M | Buy |
792,478
+19,565
| +3% | +$2.16M | 0.03% | 574 |
|
|
2015
Q1 | $88.2M | Sell |
772,913
-59,435
| -7% | -$6.78M | 0.03% | 531 |
|
|
2014
Q4 | $91.7M | Buy |
832,348
+29,874
| +4% | +$3.15M | 0.04% | 497 |
|
|
2014
Q3 | $78.3M | Sell |
802,474
-3,521
| -0.4% | -$346K | 0.03% | 540 |
|
|
2014
Q2 | $81.3M | Buy |
805,995
+38,043
| +5% | +$3.71M | 0.03% | 564 |
|
|
2014
Q1 | $70.5M | Buy |
767,952
+45,462
| +6% | +$4.19M | 0.03% | 607 |
|
|
2013
Q4 | $65.4M | Buy |
722,490
+1,402
| +0.2% | +$121K | 0.03% | 618 |
|
|
2013
Q3 | $57.5M | Sell |
721,088
-64,112
| -8% | -$5.05M | 0.03% | 618 |
|
|
2013
Q2 | $57.1M | Buy |
+785,200
| New | +$58.7M | 0.03% | 577 |
|
Other funds holding ZBH
VCM
VPM
Wells Fargo's ZBH Position: Q1 2026 in Review
Wells Fargo reduced its Zimmer Biomet (ZBH) stake by 20% in Q1 2026, selling an estimated $4.09M and leaving 179,488 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1665.
Wells Fargo first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $372M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Wells Fargo held 179,488 shares of Zimmer Biomet worth $16.2M as of Q1 2026.
- Wells Fargo sold 44,601 Zimmer Biomet shares in Q1 2026, an estimated $4.09M.
- Zimmer Biomet made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1665 holding.
- Wells Fargo first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Zimmer Biomet position peaked at $372M in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.